Alcon Investigational Agent
Sponsors
Alcon Research
Conditions
Ocular HypertensionOpen-Angle Glaucoma
Phase 3
Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-69
CompletedNCT00047515
Start: 2001-01-31End: 2003-12-31Updated: 2008-08-05
Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-70
CompletedNCT00047541
Start: 2001-02-28End: 2003-11-30Updated: 2008-08-05
Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-02-41
CompletedNCT00047528
Start: 2001-01-31End: 2003-11-30Updated: 2008-08-05